Merck & Co stops final-stage drug trial for treating PAH
Merck & Co. halted its final-phase study of its experimental drug for pulmonary arterial hypertension after previous studies proved its “robust efficacy,” according.
Drugs
Health
Medical
Drugs
Health
Medical
US ‘humanitarian wavier’ will help deliver life-saving HIV medicines: UN
The UNAIDS has welcomed a move by the United States Secretary of State, Marco Rubio, to approve an “Emergency Humanitarian Waiver” to allow.
Drugs
Health
Medical
Eli Lilly halts trials of investigational chronic kidney disease drug
Eli Lilly has stopped trials of its investigational drug to treat chronic kidney disease for a “lack of foreseeable clinical benefit,” according to.
Drugs
Health
Medical
Novo’ Nordisk’s drug to cut kidney disease advance in diabetics gets nod
Novo Nordisk’s medicine has been approved by the US drug regulator for reducing the risk of kidney failure and death due to cardiovascular.
Drugs
Health
Pharma
US aid pause to take ‘world back to 1980s, 1990s’ on fighting HIV: WHO
A US government’s decision to pause funding for HIV programmes in low and middle-income countries will take the world back to the 1980s.
Drugs
Health
Pharma
AstraZeneca-Daiichi’s breast cancer drug gets broader US nod
Anglo-Swedish AstraZeneca Plc., and Japan’s Daiichi Sankyo’s therapy to treat a certain form of breast cancer has been approved by the US drug.
Drugs
Pharma
AstraZeneca to invest $570 million in Canada to boost innovation, clinical delivery
HQ Team January 26, 2025: Pharmaceutical giant AstraZeneca has announced plans to invest US$570 million in Canada over the next decade, positioning the.
Drugs
Health
Medical
China’s YolTech starts gene editing trial for treating a blood disorder
China’s YolTech Therapeutics, a biotechnology startup, has started its clinical trial of an investigational therapy for treating transfusion-dependent beta-thalassemia (TDT), a severe genetic.
